Dr. Katie Murray discusses how advances in non–muscle invasive bladder cancer are shifting care toward a more collaborative, practice-wide model. She emphasizes the growing role of nurses and advanced practice providers in intravesical therapy delivery, patient education, and symptom management. As treatment expands beyond repeated TURBTs, Dr. Murray highlights the need for the entire care team to understand evolving protocols and toxicities.